[go: up one dir, main page]

ATE413887T1 - Stress-protein-peptidkomplexe als impfstoffe gegen intrazelluläre pathogene - Google Patents

Stress-protein-peptidkomplexe als impfstoffe gegen intrazelluläre pathogene

Info

Publication number
ATE413887T1
ATE413887T1 AT00954739T AT00954739T ATE413887T1 AT E413887 T1 ATE413887 T1 AT E413887T1 AT 00954739 T AT00954739 T AT 00954739T AT 00954739 T AT00954739 T AT 00954739T AT E413887 T1 ATE413887 T1 AT E413887T1
Authority
AT
Austria
Prior art keywords
peptide complexes
vaccines against
protein peptide
stress protein
intracellular pathogens
Prior art date
Application number
AT00954739T
Other languages
English (en)
Inventor
Camilo Colaco
Original Assignee
Immunobiology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunobiology Ltd filed Critical Immunobiology Ltd
Application granted granted Critical
Publication of ATE413887T1 publication Critical patent/ATE413887T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6043—Heat shock proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AT00954739T 1999-08-19 2000-08-18 Stress-protein-peptidkomplexe als impfstoffe gegen intrazelluläre pathogene ATE413887T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9919733.7A GB9919733D0 (en) 1999-08-19 1999-08-19 Vaccines against intracellular pathogens

Publications (1)

Publication Number Publication Date
ATE413887T1 true ATE413887T1 (de) 2008-11-15

Family

ID=10859500

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00954739T ATE413887T1 (de) 1999-08-19 2000-08-18 Stress-protein-peptidkomplexe als impfstoffe gegen intrazelluläre pathogene

Country Status (14)

Country Link
EP (1) EP1204421B1 (de)
JP (1) JP2003527322A (de)
CN (1) CN1182871C (de)
AT (1) ATE413887T1 (de)
AU (1) AU6709700A (de)
CA (1) CA2382331C (de)
DE (1) DE60040792D1 (de)
DK (1) DK1204421T3 (de)
ES (1) ES2316380T3 (de)
GB (1) GB9919733D0 (de)
IL (2) IL148154A0 (de)
PT (1) PT1204421E (de)
WO (1) WO2001013943A2 (de)
ZA (1) ZA200201357B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0910591D0 (en) 2009-06-19 2009-07-29 Immunobiology Ltd Method for the purification of protein complexes
GB0916557D0 (en) * 2009-09-21 2009-10-28 Health Prot Agency Commensal neisserial stress protein complexes
GB201104897D0 (en) 2011-03-23 2011-05-04 Immunobiology Ltd Method for the production of protein complexes and vaccine compositions comprising the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997006685A1 (en) * 1995-08-18 1997-02-27 Sloan-Kettering Institute For Cancer Research Method for treatment of cancer and infectious diseases and compositions useful in same
US5985270A (en) * 1995-09-13 1999-11-16 Fordham University Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
US5837251A (en) * 1995-09-13 1998-11-17 Fordham University Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
JPH11513369A (ja) * 1995-09-13 1999-11-16 フォーダム ユニバーシティー 熱ショックタンパク質を用いる治療及び予防方法
US6130087A (en) * 1996-10-07 2000-10-10 Fordham University Methods for generating cytotoxic T cells in vitro
US5830464A (en) * 1997-02-07 1998-11-03 Fordham University Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
US6017540A (en) * 1997-02-07 2000-01-25 Fordham University Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
GB9818133D0 (en) * 1998-08-19 1998-10-14 Quadrant Holdings Cambridge Vaccine

Also Published As

Publication number Publication date
CA2382331C (en) 2011-06-14
WO2001013943A2 (en) 2001-03-01
DK1204421T3 (da) 2009-03-09
IL148154A0 (en) 2002-09-12
CA2382331A1 (en) 2001-03-01
JP2003527322A (ja) 2003-09-16
CN1370077A (zh) 2002-09-18
IL148154A (en) 2008-11-26
CN1182871C (zh) 2005-01-05
ZA200201357B (en) 2003-07-30
PT1204421E (pt) 2009-03-18
AU6709700A (en) 2001-03-19
GB9919733D0 (en) 1999-10-20
ES2316380T3 (es) 2009-04-16
EP1204421B1 (de) 2008-11-12
EP1204421A2 (de) 2002-05-15
WO2001013943A3 (en) 2001-09-20
DE60040792D1 (de) 2008-12-24

Similar Documents

Publication Publication Date Title
PL375382A1 (en) Vaccine
DE69824013D1 (de) Impfstoff gegen hpv
MXPA05009580A (es) Vacuna contra el virus de la influenza.
ATE542829T1 (de) Impfstoff
DK1292328T3 (da) Kimære humant papillomvirus- (HPV) - molekyler og deres anvendelse
ATE402715T1 (de) Hcv-impfstoff zusammensetzungen
DK1409692T3 (da) Nye peptider afledt af G-proteinet fra RSV, og anvendelse heraf i en vaccine
NO20050396L (no) Adjuvant viral partikkel
DK1290160T3 (da) Humane Pellino-polypeptider
ATE413887T1 (de) Stress-protein-peptidkomplexe als impfstoffe gegen intrazelluläre pathogene
WO2001063278A3 (en) Antigenic fragments associated with stress-induced proteins and their use as vaccines
DE69922212D1 (de) Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp)
ATE494377T1 (de) Vakzine gegen ipnv die aus hefezellen isoliert werden
DE60043390D1 (de) Stress-proteine extrazellulärer pathogene als impfstoffe gegen infektiöse erreger
SE9903534D0 (sv) Vaccin
TW200509964A (en) VP1 of foot-and-mouth disease virus
MX2007002659A (es) Composicion vacunal contra el virus de la hepatitis c.
AR041515A1 (es) Vacuna a dna contra el virus de papiloma humano
WO2002060390A3 (en) Induction of immune responses to isoaspartyl-modified antigens
SE0002498D0 (sv) Papillomavirus vaccine
WO2005010035A3 (en) Alternate reading frame polypeptides derived from hepatitis c and methods of their use
ATE359811T1 (de) Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1204421

Country of ref document: EP